Hulio adalimumab
Hulio™ is a medicine to fight Autoimmune conditions. Certain medicines like adalimumab are based on large complex substances from the human body, so it is impossible to make exact copies. However, it is possible to make a drug called a biosimilar, which must go through a very comprehensive testing process to show that it does not to have any clinically meaningful differences from the reference product in terms of quality, safety and efficacy.
-
Hulio™
Hulio™ is a biosimilar and has proven similarity to reference adalimumab in clinical studies.
If you have been using reference adalimumab and your doctor suggests you move to Hulio™ you shouldn’t notice any difference.Hulio™ is available in a pre-filled pen or a pre filled syringe.
Hulio 40 mg solution for injection in pre-filled pen:
Hulio 40 mg solution for injection in pre-filled syringe:
-
click the + for Patient Resources
By clicking on the + symbol you confirm that you have been prescribed Hulio™Educational materials for patients in the areas of:
- Rheumatoid Arthritis, Psoriasis, and Inflammatory Bowel Disease:
RA patient information
Psoriasis patient information
IBD patient information- Injection instructions for pre-filled pen and pre-filled syringe:
Injection Booklet PEN Injection Booklet SYRINGE 
>> Download Here >> Download Here Please make sure you use HulioTM as directed by your Healthcare Professional.
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. If you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. See www.mhra.gov.uk/yellowcard for how to report side effects. By reporting side effects you can help provide more information on the safety of this medicine.
ADA-2018-0069
DOP: November 2018
